期刊
JOURNAL OF ENDOCRINOLOGY
卷 185, 期 3, 页码 R1-R8出版社
BIOSCIENTIFICA LTD
DOI: 10.1677/joe.1.06211
关键词
-
Recently visfatin was characterized as a novel adipocytokine that is upregulated in obesity and exerts insulin-mimetic effects in various tissues. To clarify expression and regulation of this adipocytokine, visfatin mRNA was measured by quantitative real-time reverse transcription-polymerase chain reaction in 3T3-L1 adipocytes during adipogenesis and after treatment with various hormones known to alter insulin sensitivity. Visfatin expression was about 6-fold higher in 3T3-L1 adipocytes in vitro as compared with epididymal fat in vivo and increased during adipogenic conversion more than 3-fold. Interestingly, 100 nM dexamethasone significantly increased visfatin mRNA by almost 1(.)5-fold. In contrast, 500 ng/ml growth hormone (GH). 10 ng/ml tumor necrosis factor (TNF) alpha,and 10 mu M isoproterenol downregulated visfatin expression by 45%, 36 0, and 43% respectively. Insulin did not influence synthesis of this adipocytokine. The effects of dexamethasone, GH, TNF alpha and isoproterenol were time- and dose-dependent. Furthermore, activation of G(S)-protein-coupled pathways by forskolin and cholera toxin was sufficient to significantly downregulate visfatin mRNA. Taken together, our results show a differential regulation of visfatin mRNA by insulin resistance-inducing hormones, supporting the view that this adipocytokine might be an interesting novel candidate linking core components of the metabolic syndrome such as obesity and insulin resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据